Association between comorbid diabetes mellitus and mortality of patients with sepsis: A meta-analysis

Author:

Du Qingxia,Yin Xuelian,Zhao Hong,Li Jiebin,Zhang Jing

Abstract

Abstract Objective Although diabetes patients have a higher propensity to develop infection and sepsis, it is still controversial whether the mortality of sepsis patients is affected by diabetes (DM). We conducted a systematic review and meta-analysis to determine the relationship between diabetes and mortality in patients with sepsis. Methods We comprehensively searched for relevant studies in PubMed, MEDLINE, EMBASE, and the Cochrane Library database from January 2000 to December 2021. Two reviewers independently selected studies, extracted data, and assessed quality. We used random-effects modeling to calculate the summary of risk ratios and confidence interval (CI) of mortality. Study quality was assessed using NOS score, and publication bias was assessed using Egger’s statistic. Results A total of 23 studies were included in the analyses, comprising 14,521,791 septic patients, including 2,866,429 DM patients. We stratified the in-hospital mortality data by duration for 30 days, 90 day, and mixed days. Meta-analysis of 23 studies showed slightly increased overall mortality among the patients with DM (RR, 1.12; 95% CI 1.00 − 1.25; I2 96.1%; = 0.000) by pooling of all data in the random effects model. Subgroup analysis did not demonstrate a statistically significant increase either in 30-day mortality (RR, 1.07; 95% CI 0.97–1.18; I2 0.0%; p 0.963), 90-day mortality (RR, 1.00; 95% CI 0.95–1.07; I2 0.0%; = 0.735), or mixed-day mortality (RR, 1.16; CI 0.98–1.37; I2 97.9%; = 0.000). The quality of the included studies was good, and the median NOS score was 7.1 (range, 6–9). Conclusions This systematic review and meta-analysis of studies suggests that DM does slightly increase sepsis overall mortality, however with statistical heterogeneity. Due to the limitations of the analysis, more well-designed clinical studies are still necessary in future.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3